NYSE : RMD

ResMed Inc. — Financial statements

Healthcare · Medical Instruments & Supplies · United States

Last price 229.94 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 32.34B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Financial statements

ResMed Inc. (RMD) reported revenue of 5.73B USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.

Income statement

Fiscal year July - June; amounts in USD.

TTMFY2026FY2025FY2024FY2023FY2022
Revenue5.73B5.65B5.15B4.69B4.22B3.58B
Cost of Revenue2.19B2.17B2.06B2.00B1.84B1.51B
Gross Profit3.54B3.48B3.09B2.69B2.39B2.06B
Selling, General & Admin1.12B1.11B991.02M917.14M874.00M737.51M
Research & Development392.49M378.29M331.28M307.52M287.64M253.57M
Amortization of Goodwill & Intangibles77.25M77.25M77.39M79.48M72.42M70.73M
Operating Expenses1.59B1.56B1.40B1.30B1.23B1.06B
Operating Income1.95B1.92B1.69B1.38B1.15B1.00B
Interest Expense-585.00K-49.72M-51.13M-22.31M
Interest & Investment Income52.30M44.71M
Earnings From Equity Investments7.35M6.96M3.64M-1.85M-7.26M-8.49M
Currency Exchange Gain (Loss)-7.29M-8.61M-2.39M-139.00K-450.00K2.81M
Other Non Operating Income (Expenses)7.58M4.66M1.83M655.00K-1.51M388.00K
EBT Excluding Unusual Items2.01B1.97B1.69B1.33B1.09B974.55M
Merger & Restructuring Charges-57.08M-33.23M-2.03M-64.23M-20.13M-1.86M
Gain (Loss) on Sale of Investments-3.10M-15.01M-10.30M-4.04M9.92M-12.20M
Pretax Income2.01B1.92B1.68B1.26B1.10B960.48M
Income Tax Expense418.61M396.12M276.84M243.85M204.11M181.05M
Net Income1.59B1.52B1.40B1.02B897.56M779.44M
Net Income to Common1.59B1.52B1.40B1.02B897.56M779.44M
Shares Outstanding (Basic)144.72M145.52M146.72M147.02M146.76M146.07M
Shares Outstanding (Diluted)145.18M146.05M147.34M147.55M147.46M147.04M
EPS (Basic)11.0110.479.556.946.125.34
EPS (Diluted)10.9810.439.516.926.095.30
Free Cash Flow1.61B1.65B1.66B1.30B573.63M216.31M
Free Cash Flow Per Share11.0811.2911.288.823.891.47
Dividend Per Share2.462.402.121.921.761.68
Gross Margin61.77%61.62%59.99%57.38%56.50%57.68%
Operating Margin34.02%33.96%32.79%29.54%27.28%28.01%
Profit Margin27.79%26.95%27.22%21.79%21.25%21.78%
Free Cash Flow Margin28.07%29.18%32.29%27.79%13.58%6.04%
EBITDA2.13B2.10B1.86B1.53B1.29B1.13B
EBITDA Margin37.09%37.07%36.15%32.73%30.60%31.47%
D&A For EBITDA176.27M175.83M173.00M149.42M140.10M124.06M
EBIT1.95B1.92B1.69B1.38B1.15B1.00B
EBIT Margin34.02%33.96%32.79%29.54%27.28%28.01%
Effective Tax Rate20.81%20.64%16.50%19.28%18.53%18.85%
Revenue as Reported5.73B5.65B5.15B4.69B4.22B3.58B

Balance sheet

Fiscal year July - June; amounts in USD.

TTMFY2026FY2025FY2024FY2023FY2022
Cash & Equivalents1.01B1.47B1.21B238.36M227.89M273.71M
Short-Term Investments9.17M
Cash & Short-Term Investments1.01B1.47B1.21B238.36M227.89M282.88M
Receivables1.02B1.08B990.67M875.46M704.91M601.64M
Inventory1.05B972.98M975.96M994.45M1.14B851.20M
Prepaid Expenses260.71M340.18M329.53M249.45M293.93M195.61M
Other Current Assets159.87M457.39M151.00K
Total Current Assets3.51B4.32B3.51B2.36B2.37B1.93B
Property, Plant & Equipment798.48M735.00M718.29M699.15M665.81M630.50M
Long-Term Investments152.13M157.38M139.82M139.20M134.11M49.21M
Goodwill2.91B2.91B3.05B2.84B2.77B1.94B
Other Intangible Assets442.68M452.74M464.86M485.90M552.34M345.94M
Long-Term Accounts Receivable13.54M14.05M14.58M18.45M10.08M8.84M
Long-Term Deferred Tax Assets344.85M329.25M253.12M203.57M132.97M79.75M
Other Long-Term Assets42.99M43.22M31.44M126.35M118.26M113.70M
Total Assets8.21B8.97B8.17B6.87B6.75B5.10B
Accounts Payable320.68M308.92M278.16M237.73M150.76M159.25M
Accrued Expenses466.62M438.57M362.33M337.89M328.48M316.89M
Current Portion of Long-Term Debt159.97M259.95M9.90M9.90M9.90M9.92M
Current Portion of Leases31.53M29.14M30.51M25.28M21.92M21.86M
Current Income Taxes Payable160.23M98.11M132.27M107.52M72.22M44.89M
Current Unearned Revenue171.65M162.91M166.03M152.55M138.07M108.67M
Other Current Liabilities13.55M97.51M39.92M39.79M37.18M27.84M
Total Current Liabilities1.32B1.40B1.02B910.65M758.53M689.30M
Long-Term Debt249.63M399.42M658.39M697.31M1.43B765.33M
Long-Term Leases169.45M137.41M153.01M141.44M116.85M120.45M
Long-Term Unearned Revenue174.21M170.95M156.80M137.34M119.19M95.45M
Long-Term Deferred Tax Liabilities62.65M64.64M77.68M79.34M90.65M9.71M
Other Long-Term Liabilities283.96M213.03M141.52M42.26M105.35M54.86M
Total Liabilities2.26B2.38B2.21B2.01B2.62B1.74B
Common Stock764.00K764.00K761.00K588.00K588.00K586.00K
Additional Paid-In Capital2.13B2.19B2.03B1.90B1.77B1.68B
Retained Earnings7.58B7.26B6.08B4.99B4.25B3.61B
Treasury Stock-3.63B-2.78B-2.07B-1.77B-1.62B-1.62B
Comprehensive Income & Other-131.74M-82.52M-74.70M-251.53M-272.53M-312.75M
Shareholders' Equity5.95B6.59B5.97B4.86B4.13B3.36B
Total Liabilities & Equity8.21B8.97B8.17B6.87B6.75B5.10B
Total Debt610.58M825.92M851.81M873.93M1.58B917.55M
Net Cash (Debt)400.16M643.32M357.64M-635.57M-1.35B-634.67M
Net Cash Per Share2.764.402.43-4.31-9.17-4.32
Filing Date Shares Outstanding140.66M144.25M146.41M146.93M147.07M146.42M
Total Common Shares Outstanding140.64M144.24M146.39M146.90M147.06M146.41M
Working Capital2.18B2.93B2.49B1.45B1.61B1.24B
Book Value Per Share42.2945.6640.7733.1128.0822.95
Tangible Book Value2.60B3.22B2.46B1.54B807.26M1.08B
Tangible Book Value Per Share18.4622.3516.7810.465.497.37
Land53.57M51.68M51.98M52.05M51.86M
Buildings236.04M230.63M231.06M231.02M229.50M
Machinery883.99M849.74M889.85M831.29M769.07M
Leasehold Improvements159.22M124.05M102.10M91.50M80.86M

Cash flow statement

Fiscal year July - June; amounts in USD.

TTMFY2026FY2025FY2024FY2023FY2022
Net Income1.59B1.52B1.40B1.02B897.56M779.44M
Depreciation & Amortization219.20M218.64M210.34M188.76M172.51M158.30M
Other Amortization19.11M25.51M25.47M27.45M25.06M35.55M
Asset Writedown & Restructuring Costs6.24M33.24M9.18M
Loss (Gain) From Sale of Investments-1.25M10.66M10.30M4.04M-9.92M12.20M
Loss (Gain) on Equity Investments-2.78M-2.38M-3.64M1.85M10.14M8.49M
Stock-Based Compensation112.66M104.35M91.66M80.18M71.14M65.26M
Other Operating Activities-20.23M
Change in Accounts Receivable-61.91M-96.78M-76.68M-134.28M-106.51M19.35M
Change in Inventory-67.02M-9.92M-80.17M172.20M-248.83M-311.68M
Change in Accounts Payable227.84M172.72M90.96M122.07M31.34M-247.63M
Change in Other Net Operating Assets-212.56M-140.26M82.63M-115.21M-138.12M-168.11M
Operating Cash Flow1.77B1.81B1.75B1.40B693.30M351.15M
Capital Expenditures-162.06M-156.28M-89.86M-99.46M-119.67M-134.84M
Cash Acquisitions-357.69M-350.72M-139.25M-133.46M-1.01B-42.78M
Sale (Purchase) of Intangibles-20.51M-20.89M-10.78M-15.40M-14.33M-21.20M
Investment in Securities-26.33M-25.78M-1.79M-11.77M-28.29M-13.92M
Other Investing Activities15.20M8.48M41.63M-9.70M15.20M-17.18M
Investing Cash Flow-100.57M-545.20M-200.04M-269.78M-1.16B-229.92M
Long-Term Debt Issued105.00M1.07B288.00M
Long-Term Debt Repaid-10.00M-40.00M-835.00M-405.00M-166.00M
Net Debt Issued (Repaid)-260.00M-10.00M-40.00M-730.00M665.00M122.00M
Issuance of Common Stock69.95M74.50M74.44M53.09M49.14M47.38M
Repurchase of Common Stock-1.51B-721.87M-318.10M-158.77M-30.63M-52.41M
Common Dividends Paid-356.87M-349.66M-310.88M-282.32M-258.28M-245.34M
Other Financing Activities-11.71M-1.29M-2.36M
Financing Cash Flow-2.05B-1.01B-606.25M-1.12B422.87M-128.36M
Foreign Exchange Rate Adjustments11.29M6.18M25.80M-1.72M-2.15M-14.43M
Net Cash Flow-373.11M259.78M971.09M10.47M-45.82M-21.57M
Free Cash Flow1.61B1.65B1.66B1.30B573.63M216.31M
Free Cash Flow Margin28.07%29.18%32.29%27.79%13.58%6.04%
Free Cash Flow Per Share11.0811.2911.288.823.891.47
Levered Free Cash Flow1.30B939.25M1.21B1.18B400.59M127.68M
Unlevered Free Cash Flow1.30B939.25M1.21B1.22B432.55M141.63M
Cash Interest Paid24.78M27.06M28.41M45.71M47.38M22.31M
Cash Income Tax Paid367.15M357.17M214.01M278.40M216.87M478.12M
Change in Working Capital-113.65M-74.24M16.74M44.78M-462.13M-708.08M

Ratios

Fiscal year July - June; amounts in USD.

TTMFY2026FY2025FY2024FY2023FY2022
Market Capitalization32.20B28.14B37.76B28.12B32.13B30.69B
Enterprise Value31.80B27.33B37.67B29.02B33.62B31.30B
Last Close Price229.94194.32254.77187.34211.59201.43
PE Ratio20.8518.4826.9627.5435.8039.38
Forward PE18.5016.4225.3222.8630.8234.10
PS Ratio5.644.987.346.007.618.58
PB Ratio5.444.276.335.787.789.13
P/TBV Ratio12.458.7315.3718.3039.8028.46
P/FCF Ratio20.1017.0622.7321.6056.02141.88
P/OCF Ratio18.2615.5921.5620.0746.3587.40
PEG Ratio2.291.161.651.542.392.45
EV/Sales Ratio5.574.837.326.207.968.75
EV/EBITDA Ratio15.0213.0420.2518.9326.0227.80
EV/EBIT Ratio16.3814.2322.3220.9729.1831.24
EV/FCF Ratio19.8516.5722.6722.3058.60144.71
Debt / Equity Ratio0.100.120.140.180.380.27
Debt / EBITDA Ratio0.280.390.450.561.190.79
Debt / FCF Ratio0.380.500.510.672.754.24
Net Debt / Equity Ratio-0.07-0.10-0.060.130.330.19
Net Debt / EBITDA Ratio-0.19-0.31-0.190.411.050.56
Net Debt / FCF Ratio-0.25-0.39-0.210.492.362.93
Asset Turnover0.690.660.680.690.710.73
Inventory Turnover2.172.232.091.871.842.30
Quick Ratio1.541.832.161.221.231.28
Current Ratio2.653.103.442.593.122.80
Return on Equity (ROE)26.40%24.27%25.86%22.70%23.96%24.96%
Return on Assets (ROA)14.76%14.00%14.02%12.70%12.15%12.75%
Return on Invested Capital (ROIC)26.88%26.38%25.36%20.35%19.81%22.04%
Return on Capital Employed (ROCE)28.30%25.40%23.60%23.20%19.20%22.70%
Earnings Yield4.80%5.41%3.71%3.63%2.79%2.54%
FCF Yield4.97%5.86%4.40%4.63%1.79%0.70%
Dividend Yield1.15%1.23%0.82%1.00%0.81%0.80%
Payout Ratio24.05%22.95%22.19%27.65%28.78%31.48%
Buyback Yield / Dilution1.35%0.87%0.14%-0.06%-0.28%-0.40%
Total Shareholder Return2.50%2.10%0.96%0.94%0.53%0.40%